Ikonisys
Business Services · Connecticut, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
5 Science Park, New Haven, Connecticut, ...Phone Number
(203) 776-0791Website
www.ikonisys.comRevenue
<$5 MillionStock Symbol
ALIKOIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Ikonisys
Ikonisys SA is a cell-based diagnostics company based in Paris (France), New Haven (Connecticut, USA) and Milan (Italy) specialized in the early and accurate detection of cancer. The company develops, produces and markets the proprietary Ikoniscope20® platform, a fully-automated solution designed to deliver accurate and reliable detection and analysis of rare cells. Ikonisys has received FDA clearance for several automated diagnostic applications, which are also marketed in Europe under CE certification. Through its breakthrough fluorescence microscopy platform, the company continues to develop a stream of new tests, including liquid biopsy tests based on Circulating Tumor Cells (CTC).Explore more
Ikonisys Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ikonisys your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if Ikonisys had a recent Job posting/layoffs
Check if Ikonisys has recently received funding, and reach out quickly before it becomes old news!
Check out if Ikonisys is spiking on competitors!
Product Launch: Get notified when Ikonisys launches new products
Ikonisys, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Ikonisys recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Ikonisys
Funding: Get notified immidiatlly once Ikonisys has new funding data
Recommended Actions
Find VP level buyers at Ikonisys
Find 2 more new buyers
Compare Similar Companies to Ikonisys
Compare insights from companies similar to Ikonisys, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Ikonisys is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Ikonisys is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Ikonisys.
Ikonisys financials insights
Gather financial insights about Ikonisys, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2010
Unspecified
$3.8M
2012
Unspecified
$1.4M
2021
Debt
$117K
2022
Debt
$6.3M
2023
Share Placement
$535K
2024
Share Placement
$208K
2025
Other Financing Round
$541K
Ikonisys Tech Stack
A closer look at the technologies used by Ikonisys
Most Recent Scoops
Funding
Funding
Funding
Funding
Mergers & Acquisitions (M&A)
Funding
Funding
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ikonisys
Sign Up For FreeTo access detailed company insights
Ikonisys SA is a cell-based diagnostics company based in Paris (France), New Haven (Connecticut, USA) and Milan (Italy) specialized in the early and accurate detection of cancer. The company develops, produces and markets the proprietary Ikoniscope20® platform, a fully-automated solution designed to deliver accurate and reliable detection and analy... Read More
